Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01010015 | Pentadecanoic acid | Lipid-depleted/compactin | 0.0 | BCD100322A002 | 15.3 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | Lipid-depleted/compactin | 0.5 | BCD100322A005 | 17.6 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | Lipid-depleted/compactin | 1.0 | BCD100322A009 | 11.5 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | Lipid-depleted/compactin | 2.0 | BCD100322A013 | 16.4 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | Lipid-depleted/compactin | 4.0 | BCD100322A017 | 7.99 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | Lipid-depleted/compactin | 8.0 | BCD100322A021 | 13.1 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | Lipid-depleted/compactin | 12.0 | BCD100322A025 | 8.13 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | Lipid-depleted/compactin | 24.0 | BCD100322A029 | 7.01 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | C | 0.0 | BCD100322A001 | 5.42 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | C | 0.5 | BCD100322A003 | 9.61 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | C | 1.0 | BCD100322A007 | 15.8 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | C | 2.0 | BCD100322A011 | 4.77 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | C | 4.0 | BCD100322A015 | 8.78 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | C | 8.0 | BCD100322A019 | 8.78 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | C | 12.0 | BCD100322A023 | 11.4 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | C | 24.0 | BCD100322A027 | 11.6 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A006 | 13.1 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A010 | 10.3 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A014 | 1.9 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A018 | 8.9 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A022 | 6.64 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A026 | 15.9 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A030 | 4.59 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol | 0.5 | BCD100322A004 | 8.87 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol | 1.0 | BCD100322A008 | 15.3 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol | 2.0 | BCD100322A012 | 3.59 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol | 4.0 | BCD100322A016 | 5.2 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol | 8.0 | BCD100322A020 | 13.9 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol | 12.0 | BCD100322A024 | 15.3 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol | 24.0 | BCD100322A028 | 6.2 | pmol/sample |